Lv1
60 积分 2025-06-05 加入
Niraparib/Abiraterone Acetate (Akeega) for Prostate Cancer
15天前
已关闭
Empowering PARP inhibition through rational combination: Mechanisms of PARP inhibitors and combinations with a focus on the treatment of metastatic castration-resistant prostate cancer
15天前
已关闭
Expert opinion on current treatment alternatives for patients with prostate cancer progressing from the metastatic hormone-sensitive stage to the castration-resistant stage after receiving early treatment intensification
15天前
已关闭
Highlights of recent research focused on the treatment of advanced prostate cancer
15天前
已关闭
Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal
15天前
已完结
Recent progress in treating advanced prostate cancer
23天前
已完结
Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal
24天前
已关闭
Taxane-based Combination Therapies for Metastatic Prostate Cancer
24天前
已完结
The evolving options in metastatic castration-sensitive prostate cancer
24天前
已完结
Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC)
24天前
已完结
皖公网安备34019202002308
